Ropes & Gray advised Sanofi on the deal. Sanofi announced a strategic equity investment in Torino, Italy-based Resalis Therapeutics (Resalis Therapeutics). The company plans to use...
You must be a Standard 1 Year member to access this content.
Freshfields Bruckhaus Deringer is advising Sanofi, while Kirkland & Ellis and Debevoise & Plimpton are advising CD&R on the transaction. French drugmaker Sanofi and Clayton Dubilier...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Sanofi in the transaction, and Wilson Sonsini Goodrich & Rosati represented Ventyx Biosciences, Inc. Sanofi announced a $27 million strategic investment in...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Sanofi on the transaction, and Goodwin Procter advised Vigil Neuroscience. Sanofi (Nasdaq: SNY) has made a $40 million strategic investment in Vigil...
You must be a Standard 1 Year member to access this content.
On the deal, Doc Generici is supported by Bird&Bird for the legal aspects, by Latham & Watkins for the financial ones and by PedersoliGattai for the...
You must be a Standard 1 Year member to access this content.
Paul, Weiss, Rifkind, Wharton and Garrison LLP is serving as legal counsel to Inhibrx, and Weil, Gotshal & Manges LLP is serving as legal counsel to...
You must be a Standard 1 Year member to access this content.
df-mp Dörries Frank-Molnia & Pohlman and Bardehle Pagenberg advised Amgen, while Zwicker Schnappauf & Partne and Carpmaels & Ransford advised Sanofi. As part of their global...
You must be a Standard 1 Year member to access this content.
Herbert Smith Freehills has advised Sanofi on the deal. The innnovative global healthcare company Sanofi announced its €300 million strategic equity investment in Chinese biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
Herbert Smith Freehills and its joint operation partner Kewei advised Sanofi on the deal. Sanofi participated in the initial public offering and listing of ClouDr in...
You must be a Standard 1 Year member to access this content.
White & Case advised Sanofi. Clifford Chance has advised the global coordinators and joint lead managers. Sanofi has finalized a double-tranche bond issue, including an inaugural...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Amunix on the deal, while Weil, Gotshal & Manges advised Sanofi. Amunix, an immuno-oncology company, announced its pending acquisition by Sanofi, a global...
You must be a Standard 1 Year member to access this content.
Schoenherr advises Sanofi on the deal, while Binder Grösswang advised the seller and CEO Sanja Selak. Sanofi completed the acquisition of 100 % of the shares...
You must be a Standard 1 Year member to access this content.
